David A Fruman

David L Woodland

PI 3-Kinase Signaling Pathways in Disease

All cancers but non-melanoma skin cancer

David A Fruman

TOR Kinase Inhibitors for Leukemia Therapy: Mechanisms of Action and Resistance

Leukaemia

Hematology and hematologic malignancies Pathology